Clinical outcomes of a new extended range of vision intraocular lens: International Multicenter Concerto Study
Author:
- Béatrice CochenerBCBéatrice Cochener
- 1 September 2016
- journal article
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 42 (9) , 1268-1275
Abstract
To analyze the clinical outcomes after implantation of an extended range of vision intraocular lens (IOL), the Tecnis Symfony, in a routine clinical setting. Forty clinical sites in Finland, France, Germany, Norway, Spain, Sweden, and the United Kingdom. Prospective case series. The study comprised 411 patients who had bilateral implantation of the extended range of vision IOL, with intended micro-monovision in 1 group (monovision group) and intended emmetropia in the other group (non-monovision group). Visual acuity, spectacle independence, patient and surgeon satisfaction, and photic phenomena were analyzed during the 4- to 6-month follow-up. The monovision group comprised 112 patients and the non-monovision group, 299 patients. The mean decimal uncorrected distance (UDVA), intermediate (UIVA), and near (UNVA) visual acuities were 0.95, 0.81, and 0.69, respectively, 4 to 6 months postoperatively. Significantly better UIVA (P = .003) and UNVA (P = .011) were found in the monovision group than in the non-monovision group. Spectacle independence was high, with 14.4% of eyes requiring reading spectacles frequently. More than 90% of patients reported no or mild halos, glare, starbursts, or other photic phenomena. Patient satisfaction scores (median) for distance, intermediate, and near vision were 9.0, 10.0, and 8.0, respectively. The satisfaction score for near vision increased to 9.0 in the monovision group. More than 91% of patients said they would recommend the same procedure to their friends and family. The extended range of vision IOL provided successful visual restoration across all distances after cataract surgery, with a minimal level of disturbing photic phenomena and high levels of patient satisfaction. Dr. Cochener is a clinical investigator for Revision Optics, Inc., Horus Vision LLC, Alcon Laboratories, Inc., Abbott Medical Optics, Inc., Théa Pharma GmbH, and Santen, Inc.; she is also a consultant to Alcon Laboratories, Inc., Abbott Medical Optics, Inc., Théa Pharma GmbH, and Santen, Inc.Keywords
This publication has 23 references indexed in Scilit:
- Clinical evaluation of a new pupil independent diffractive multifocal intraocular lens with a +2.75 D near addition: a European multicentre studyBritish Journal of Ophthalmology, 2015
- Clinical Outcomes With a Trifocal Intraocular Lens: A Multicenter StudyJournal of Refractive Surgery, 2014
- Comparative Analysis of the Visual Performance After Cataract Surgery With Implantation of a Bifocal or Trifocal Diffractive IOLJournal of Refractive Surgery, 2014
- Working-Age Cataract Patients: Visual Results, Reading Performance, and Quality of Life with Three Diffractive Multifocal Intraocular LensesOphthalmology, 2014
- Outcomes of a new diffractive trifocal intraocular lensJournal of Cataract & Refractive Surgery, 2014
- Clinical Outcomes with a New Trifocal Intraocular LensEuropean Journal of Ophthalmology, 2013
- Theoretical Performance of Intraocular Lenses Correcting Both Spherical and Chromatic AberrationJournal of Refractive Surgery, 2012
- New intraocular lens for achromatizing the human eyeJournal of Cataract & Refractive Surgery, 2007
- Theoretical Comparison of Aberration-correcting Customized and Aspheric Intraocular LensesJournal of Refractive Surgery, 2007
- The chromatic eye: a new reduced-eye model of ocular chromatic aberration in humansApplied Optics, 1992